Nutrition Education Program for Type 2 Diabetes and Colorectal Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a special education program can help people with Type 2 diabetes learn more about preventing colorectal cancer, improve their diets, and increase screening frequency. Participants will either receive this tailored education, which includes eight sessions and a workbook, or continue with their usual care. The study seeks to understand what encourages people with diabetes to get screened for colorectal cancer and whether this education can make a difference. Individuals with Type 2 diabetes who are African American or Hispanic and visit a participating clinic might be suitable for this trial. As an unphased study, this trial offers a unique opportunity to contribute to important research that could enhance health education and screening practices for people with diabetes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on education about nutrition and colorectal cancer prevention, so it's unlikely that medication changes are required.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on education about nutrition and colorectal cancer prevention, so it's unlikely that medication changes are required.
What prior data suggests that this education program is safe for participants?
This study involves an educational program focused on preventing colorectal cancer and promoting healthy eating for individuals with Type 2 diabetes. It does not involve drugs or medical procedures, eliminating safety risks or side effects typically associated with medications.
The program consists of eight educational sessions and a booklet designed to teach participants about cancer prevention and healthy eating. As a learning program, it is safe for all participants.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a new approach to managing Type 2 Diabetes and Colorectal Cancer through education rather than medication. Unlike standard treatments such as insulin therapy or chemotherapy, this program offers a personalized, culturally sensitive education plan. Participants receive eight sessions covering nutrition and colorectal cancer, with supportive materials to reinforce learning. This could empower patients to manage their health proactively, potentially improving outcomes and quality of life.
What evidence suggests that this education program is effective for increasing colorectal cancer knowledge and screenings in patients with Type 2 diabetes?
This trial will compare a personalized nutrition education program to usual care. Research has shown that such a program can improve dietary habits in people with colorectal cancer, increasing calorie and protein intake, which benefits their health. Studies have also found that these programs can boost colorectal cancer screening rates, particularly among individuals with type 2 diabetes. This is crucial because diabetes can raise the risk of colorectal cancer by 47%. The program aims to increase awareness of this risk and promote healthier eating habits.12345
Who Is on the Research Team?
Lucy Kibe, DrPH
Principal Investigator
Charles Drew University of Medicine and Science
Are You a Good Fit for This Trial?
This trial is for minority individuals aged 35-75 with Type 2 diabetes, who have visited KCHC in the past two years and can provide contact information. It's not for those with certain digestive diseases, a history of colorectal cancer or related treatments, cognitive impairments, or those already in another diet program.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Education Program
Participants receive a customized patient-centered, culturally appropriate education program, including eight education sessions and a workbook on colorectal cancer and nutrition.
Follow-up
Participants are monitored for changes in colorectal cancer knowledge, perceptions, and dietary indices immediately and 6 months post-intervention.
What Are the Treatments Tested in This Trial?
Interventions
- Intervention Group (IG)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Charles Drew University of Medicine and Science
Lead Sponsor